← Leaderboards
Jerzy Golik
Makscientific, Llc
$2,039,971
Attributed
$2,039,971
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2007–11$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$2,039,971 · 4
By mechanism
R44$1,005,888 · 1
N44$750,000 · 1
R43$284,083 · 2
Top collaborators
No co-investigators on record.
Most similar at Makscientific, Llc
Same institution · by research overlap
- Shakiru Olajire Alapafuja$2,913,513
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsAnalogNeurodegenerative DisordersGenerationsLeadBaseDrug Of AbuseAnandamideAlzheimer&AposExcitotoxicityIn VivoKainic AcidComputer SimulationBehavioralEndocannabinoidsBiochemicalDesignBiological AvailabilityBrainBrain InjuriesCannabinoid ReceptorEvaluationIn VitroInhibitor/Antagonist
Grant awards (6)
New Drugs to Enhance Endocannabinoid Responses for Treating Excitotoxicity, Phase$516,628
R44 · FY2011 · DA · contact PI
NOVEL AZETIDINE CB1 ANTAGONISTS$23,826
N44 · FY2010 · DA · contact PI
NOVEL AZETIDINE CB1 ANTAGONISTS$726,174
N44 · FY2009 · DA · contact PI
New Drugs to Enhance Endocannabinoid Responses for Treating Excitotoxicity, Phase$489,260
R44 · FY2009 · DA · contact PI
New Drugs to Enhance Endocannabinoid Responses for Treating Excitotoxicity$130,066
R43 · FY2007 · DA · contact PI
CB1 Receptor Antagonists in Drug Abuse$154,017
R43 · FY2004 · DA